Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03882827 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Natural History of Duchenne Muscular Dystrophy

StatusRecruiting
PhaseNot specified
SponsorGenethon
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 100 to 220v12 Show 6 more changesShow less
    • Primary completion date: Jun 30, 2023 to May 30, 2029
    • Primary endpoints: 10 to 11
    • Study sites: 9 to 15
    • Study completion date: Jun 30, 2023 to Sep 30, 2029
    • Eligibility criteria expanded, about 100 words
    • Study description shortened, about 14 words
  2. Site details revised at 2 of 9 sitesv11
  3. Study sites: 4 to 9v10
  4. Site details revised at 1 of 4 sitesv9
  5. Enrollment target: 30 to 100v8 Show 5 more changesShow less
    • Primary and study completion dates: Jun 30, 2022 to Jun 30, 2023
    • Primary endpoints: 9 to 10
    • Study sites: 3 to 4
    • Eligibility criteria expanded, about 22 words
    • Study description revised
Show 6 earlier versionsHide 6 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 1, 2019 to Dec 19, 2019
    • Site details revised at 3 of 3 sites
    v7
  2. Primary completion date: Apr 30, 2021 to Jun 30, 2022
    • Start date: Sep 15, 2019 to Dec 1, 2019
    • Study completion date: Oct 30, 2021 to Jun 30, 2022
    v6
  3. Start date: Jun 30, 2019 to Sep 15, 2019v5
  4. Start date: Apr 30, 2019 to Jun 30, 2019v4
  5. Primary endpoints: 1 to 9
    • Study sites: 5 to 3
    • Eligibility criteria shortened, about 35 words
    • Study description revised
    v3
  6. Study sites: 2 to 5v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Baseline Study on Duchenne Muscular Dystrophy (DMD) in view to collect data on the natural disease course in a cohort in young male subjects aged from 4 to 9 Years over a period of 6 to 36 months using disease appropriate evaluations.
Trial Details
NCT Number NCT03882827
Lead Sponsor Genethon
Conditions
(from sponsor)		 Duchenne Muscular Dystrophy
Related terms Muscular Dystrophy, Duchenne
Enrollment 220 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov